LAG3 and neoplasm: The presence of some activating receptors such as OX40 and ICOS was increased in the surface of CD8 cells in the tumor (Figure 3b), whereas the inhibitory receptor LAG3 was reduced in tumor-specific CD8+ T lymphocytes.